Advanced search    

Search: authors:"Jan Paul Ottervanger"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Impact of new X-ray technology on patient dose in pacemaker and implantable cardioverter defibrillator (ICD) implantations

Purpose New X-ray technology providing new image processing techniques may reduce radiation exposure. The aim of this study was to quantify this radiation exposure reduction for patients during pacemaker and implantable cardioverter defibrillator (ICD) implantation. Methods In this retrospective study, 1185 consecutive patients who had undergone de novo pacemaker or ICD...

High-risk coronary artery disease, but normal myocardial perfusion: A matter of concern?

Ottervanger MD , PhD, FESC , Department of Cardiology, Isala hospital , Zwolle , Netherlands 1 Department of Cardiology, Isala Hospital , Zwolle , Netherlands - ischemic left ventricle dilatation or abnormal

Value of automatic patient motion detection and correction in myocardial perfusion imaging using a CZT-based SPECT camera

Background Correction of motion has become feasible on cadmium-zinc-telluride (CZT)-based SPECT cameras during myocardial perfusion imaging (MPI). Our aim was to quantify the motion and to determine the value of automatic correction using commercially available software. Methods and Results We retrospectively included 83 consecutive patients who underwent stress-rest MPI CZT...

Impact of Routine Stenting on Clinical Outcome in Diabetic Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction

GIUSEPPE DE LUCA HARRY SURYAPRANATA JORIK TIMMER JAN PAUL OTTERVANGER ARNOUD W.J. VAN'T HOF JAN C.A. HOORNTJE JAN-HENK DAMBRINK A.T. MARCEL GOSSELINK MENKO-JAN DE BOER T patients with ST-segment

Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison

Background Despite their proven beneficial effects and inclusion in the guidelines, glycoprotein (GP) IIb/IIIA blockers are underused in daily practice in patients with non ST-segment elevation acute coronary syndrome (NSTE ACS). This study combines the data from two randomized controlled trials, comparing routine upstream versus selective down stream use of tirofiban in patients...

Diabetes Does Not Influence Treatment Decisions Regarding Revascularization in Patients With Stable Coronary Artery Disease

ARNO BREEMAN MICHEL E. BERTRAND PHD JAN PAUL OTTERVANGER PHD SANNE HOEKS MSC 0 MATTIE LENZEN MSC 0 UDO SECHTEM PHD VICTOR LEGRAND PHD 0 ON BEHALF OF THE INVESTIGATORS OF THE OBJECTIVE - To evaluate